Clinical trial
Safety and Acceptability of Carraguard® in HIV Positive Women and Men
NCT00213005 · Population Council, Other · Completed
Key facts
| NCT number | NCT00213005 |
|---|---|
| Title | Safety and Acceptability of Carraguard® in HIV Positive Women and Men |
| Official title | A Phase 1 Safety and Acceptability Study of Carraguard® Among HIV Positive Women and Men in Durban, South Africa |
| Lead sponsor | Population Council, Other |
| Collaborators | Centers for Disease Control and Prevention U.S. Fed Medical Research Council |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Carraguard (PC-515) |
| Enrollment | 60 |
| Start date | Jun 1, 2002 |
| Completion | Aug 1, 2003 |
| First posted | Sep 21, 2005 |
| Last update posted | Aug 14, 2017 |
| Countries | South Africa |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: